214 related articles for article (PubMed ID: 23918735)
1. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.
Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED
J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y
J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688
[TBL] [Abstract][Full Text] [Related]
3. An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.
Zheng MQ; Kim SJ; Holden D; Lin SF; Need A; Rash K; Barth V; Mitch C; Navarro A; Kapinos M; Maloney K; Ropchan J; Carson RE; Huang Y
J Nucl Med; 2014 Jul; 55(7):1185-91. PubMed ID: 24854795
[TBL] [Abstract][Full Text] [Related]
4. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
[TBL] [Abstract][Full Text] [Related]
5. Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.
Naganawa M; Zheng MQ; Nabulsi N; Tomasi G; Henry S; Lin SF; Ropchan J; Labaree D; Tauscher J; Neumeister A; Carson RE; Huang Y
J Cereb Blood Flow Metab; 2014 Nov; 34(11):1818-25. PubMed ID: 25182664
[TBL] [Abstract][Full Text] [Related]
6. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
[TBL] [Abstract][Full Text] [Related]
8. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
Li S; Zheng MQ; Naganawa M; Kim S; Gao H; Kapinos M; Labaree D; Huang Y
J Nucl Med; 2019 Jul; 60(7):1023-1030. PubMed ID: 30630942
[TBL] [Abstract][Full Text] [Related]
9. Kinetic Modeling and Test-Retest Reproducibility of
Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
[TBL] [Abstract][Full Text] [Related]
10. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
11. Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.
Tomasi G; Nabulsi N; Zheng MQ; Weinzimmer D; Ropchan J; Blumberg L; Brown-Proctor C; Ding YS; Carson RE; Huang Y
J Nucl Med; 2013 Apr; 54(4):600-8. PubMed ID: 23424192
[TBL] [Abstract][Full Text] [Related]
12. Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050.
Naganawa M; Dickinson GL; Zheng MQ; Henry S; Vandenhende F; Witcher J; Bell R; Nabulsi N; Lin SF; Ropchan J; Neumeister A; Ranganathan M; Tauscher J; Huang Y; Carson RE
J Pharmacol Exp Ther; 2016 Feb; 356(2):260-6. PubMed ID: 26628406
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors.
Cai Z; Li S; Pracitto R; Navarro A; Shirali A; Ropchan J; Huang Y
ACS Chem Neurosci; 2017 Jan; 8(1):12-16. PubMed ID: 27741398
[TBL] [Abstract][Full Text] [Related]
14. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
[TBL] [Abstract][Full Text] [Related]
15. PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age.
Vijay A; Cavallo D; Goldberg A; de Laat B; Nabulsi N; Huang Y; Krishnan-Sarin S; Morris ED
Neuropsychopharmacology; 2018 Dec; 43(13):2539-2547. PubMed ID: 30188515
[TBL] [Abstract][Full Text] [Related]
16. Reaching out for Sensitive Evaluation of the Mu Opioid Receptor in Vivo: Positron Emission Tomography Imaging of the Agonist [
Rafique W; Khanapur S; Spilhaug MM; Riss PJ
ACS Chem Neurosci; 2017 Sep; 8(9):1847-1852. PubMed ID: 28590714
[TBL] [Abstract][Full Text] [Related]
17. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
Talbot PS; Narendran R; Butelman ER; Huang Y; Ngo K; Slifstein M; Martinez D; Laruelle M; Hwang DR
J Nucl Med; 2005 Mar; 46(3):484-94. PubMed ID: 15750163
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
[TBL] [Abstract][Full Text] [Related]
19. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.
Placzek MS; Van de Bittner GC; Wey HY; Lukas SE; Hooker JM
Neuropsychopharmacology; 2015 Dec; 40(13):2865-72. PubMed ID: 26058662
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
